Authors: Alice Weatherston
A new condition or disease status, termed Mild Behavioral Impairment (MBI) has been described by researchers from the University of Calgary (AB, Canada) and presented at the ongoing Alzheimer’s Association International Conference 2016 (22 – 28th July 2016, ON, Canada). Early findings indicate that the condition may represent a precursor to neurodegeneration and progression to either mild cognitive impairment or dementia.
The University of Calgary team define MBI as a syndrome of later-life acquired neuropsychiatric symptoms that persist for at least 6 months. As part of the study the researchers developed an MBI checklist for utilization by physicians in a younger predementia population. The checklist focuses on five categories of behavioral symptoms that represent what they believe may be behavior changes most associated with the beginnings of neurodegeneration; apathy/drive/motivation, mood/affect/anxiety, impulse control/agitation/reward, social appropriateness and thoughts/perception.